The effect of estrone on thrombin generation may explain the different thrombotic risk between oral and transdermal hormone replacement therapy

Bagot, C.N., Marsh, M.S., Whitehead, M., Sherwood, R., Roberts, L., Patel, R.K. and Arya, R. (2010) The effect of estrone on thrombin generation may explain the different thrombotic risk between oral and transdermal hormone replacement therapy. Journal of Thrombosis and Haemostasis, 8(8), pp. 1736-1744. (doi:10.1111/j.1538-7836.2010.03953.x) (PMID:20553380)

Full text not currently available from Enlighten.

Abstract

BACKGROUND: The metabolism of estrogen contained within hormone replacement therapy (HRT) is influenced by the route of administration, and this may affect the risk of venous thromboembolism. Thrombin generation, a global coagulation assay, is a marker of hypercoagulability and is of potential use in determining the thrombotic risk associated with particular HRT administration routes.

OBJECTIVES: To determine whether any effect of oral and transdermal HRT on thrombin generation is related to the plasma estrogen profile.

METHODS: We investigated the effects of oral, transdermal and no HRT (controls) in 52, 39 and 52 postmenopausal women, respectively, on thrombin generation, standard markers of thrombophilia, estradiol level and estrone level.

RESULTS: All parameters of thrombin generation were altered in women using oral HRT as compared with controls (P<0.001 for all comparisons). No such differences were found in women using transdermal HRT. Estrone levels correlated with peak thrombin generation (R=0.451, P<0.001) in women using oral HRT, but there was no correlation in women using the transdermal route.

CONCLUSIONS: Thrombin generation is significantly increased in women who use HRT administered by the oral route. This is probably mediated by the hepatic first-pass metabolism of estrone, the main metabolite of oral estradiol, which is avoided by the transdermal route. The effect of estrone on thrombin generation may provide the explanation for the higher thrombotic risk seen in women using oral rather than transdermal HRT.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Bagot, Dr Catherine
Authors: Bagot, C.N., Marsh, M.S., Whitehead, M., Sherwood, R., Roberts, L., Patel, R.K., and Arya, R.
College/School:College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing
Journal Name:Journal of Thrombosis and Haemostasis
Publisher:Blackwell Publishing
ISSN:1538-7933
ISSN (Online):1538-7836

University Staff: Request a correction | Enlighten Editors: Update this record